Literature DB >> 15327594

Severe overdosage with the antiepileptic drug oxcarbazepine.

J M van Opstal1, R Janknegt, J Cilissen, W H V M L'Ortije, J E Nel, F De Heer.   

Abstract

Few published human data are available concerning the acute toxicity of the new antiepileptic drug oxcarbazepine of which the metabolite 10- monohydroxy derivate (MHD) is the pharmacologically effective compound. Two hours after a documented overdosage of more than 100 tablets oxcarbazepine, the serum level of the parent compound was 10-fold higher than the therapeutic dosage (31.6 mg l(-1)). However, the concentration of MHD, which peaked 7 h after intake, was only twofold higher (59.0 mg l(-1)). No life-threatening situations occurred and the patient fully recovered. The fact that oxcarbazepine is a prodrug and that the formation of the active MHD metabolite is a rate-limiting process may contribute to the relative low toxicity of the drug in overdose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327594      PMCID: PMC1884557          DOI: 10.1111/j.1365-2125.2004.02129.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

Review 1.  Therapeutic drug monitoring of the newer antiepileptic drugs.

Authors:  Svein I Johannessen; Dina Battino; David J Berry; Meir Bialer; Günter Krämer; Torbjörn Tomson; Philip N Patsalos
Journal:  Ther Drug Monit       Date:  2003-06       Impact factor: 3.681

2.  Oxcarbazepine, risperidone and atenolol overdose with benign outcome.

Authors:  Michele Raja; Antonella Azzoni
Journal:  Int J Neuropsychopharmacol       Date:  2003-09       Impact factor: 5.176

Review 3.  Oxcarbazepine in the treatment of epilepsy.

Authors:  T A Glauser
Journal:  Pharmacotherapy       Date:  2001-08       Impact factor: 4.705

4.  Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures.

Authors:  A W Wamil; M Schmutz; C Portet; K F Feldmann; M J McLean
Journal:  Eur J Pharmacol       Date:  1994-12-27       Impact factor: 4.432

Review 5.  Oxcarbazepine: mechanisms of action.

Authors:  M J McLean; M Schmutz; A W Wamil; H R Olpe; C Portet; K F Feldmann
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

6.  Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.

Authors:  G Flesch; D Tudor; C Souppart; J D'Souza; M Hossain
Journal:  Int J Clin Pharmacol Ther       Date:  2002-11       Impact factor: 1.366

7.  Hyponatremia induced by oxcarbazepine in children.

Authors:  P Borusiak; E Korn-Merker; N Holert; H E Boenigk
Journal:  Epilepsy Res       Date:  1998-05       Impact factor: 3.045

  7 in total
  2 in total

1.  Acute oxcarbazepine overdose in an autistic boy.

Authors:  Maura Pedrini; Antoni Noguera; Joan Vinent; Mercè Torra; Rafael Jiménez
Journal:  Br J Clin Pharmacol       Date:  2009-02-26       Impact factor: 4.335

2.  Suicidality in people taking antiepileptic drugs: What is the evidence?

Authors:  Gail S Bell; Marco Mula; Josemir W Sander
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.